Viewing data from:

LEVOCETIRIZINE DIHYDROCHLORIDE

ANDA

LEVOCETIRIZINE DIHYDROCHLORIDE | A090199 | TEVA PHARMACEUTICALS USA

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.0534

per ea

Lowest NADAC/Unit

$0.0534

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00093770198LEVOCETIRIZINE 5 MG TABLET	$0.0534	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain11 active DMFs2 inactive

11 active API suppliers hold Drug Master Files for this ingredient.

CIPLA LTDLEVOCETIRIZINE DIHYDROCHLORIDE USP

DMF 201732007

GLOCHEM INDUSTRIES PRIVATE LTDLEVOCETIRIZINE DIHYDROCHLORIDE USP

DMF 211102007

SUN PHARMACEUTICAL INDUSTRIES LTDLEVOCETIRIZINE DIHYDROCHLORIDE

DMF 212142008

COHANCE LIFESCIENCES LTDLEVOCETIRIZINE DIHYDROCHLORIDE USP

DMF 214172008

SYMED LABS LTDLEVOCETIRIZINE DIHYDROCHLORIDE

DMF 222862008

ALIVUS LIFE SCIENCES LTDLEVOCETIRIZINE DIHYDROCHLORIDE USP

DMF 226772009

GRANULES INDIA LTDLEVOCETIRIZINE DIHYDROCHLORIDE USP

DMF 228982009

TARO PHARMACEUTICAL INDUSTRIES LTDLEVOCETIRIZINE DIHYDROCHLORIDE USP

DMF 243432010

JUBILANT BIOSYS LTDLEVOCETIRIZINE DIHYDROCHLORIDE USP

DMF 252792012

CHROMO LABORATORIES INDIA PRIVATE LTDLEVOCETIRIZINE DIHYDROCHLORIDE USP

DMF 332192019

METROCHEM API PRIVATE LTDLEVOCETIRIZINE DIHYDROCHLORIDE USP

DMF 347312020

WAVELENGTH ENTERPRISES LTDInactiveLEVOCETIRIZINE DIHYDROCHLORIDE

DMF 241612010

SYNTHON BVInactiveLEVOCETIRIZINE DIHYDROCHLORIDE

DMF 245612011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Aug 22, 2011

No patent or exclusivity listings for this strength.